BCIQ Profiles

Company Profile Report
0422 Code Biotherapeutics
BioCentury & Getty Images

Emerging Company Profile

Code Bio: Using DNA scaffolds to deliver non-viral gene therapies

Emerging Company Profile: Code Bio aims to deliver larger genetic material than viral vectors can hold

Code Bio aims to deliver larger genetic material than viral vectors can hold.

Apr 22, 2021 | 11:06 PM GMT

Non-viral gene therapy start-up Code Bio believes its synthetic DNA vectors will allow it to deliver payloads that viral vectors cannot, opening up broader possibilities for the modality including repeat dosing, specific

Read the full 838 word article

How to gain access

Continue reading with a
two-week free trial.